Improving Public Cancer Care by Implementing Precision Medicine in Norway

Condition:   Cancer Metastatic Intervention:   Drug: Atezolizumab Sponsors:   Oslo University Hospital;   Haukeland University Hospital;   St. Olavs Hospital;   University Hospital of North Norway;   University Hospital, Akershus;   Vestre Viken Hospital Trust;   Hospital of Southern Norway Trust;   Ostfold Hospital Trust;   The Hospital of  Vestfold;   Helse Stavanger HF;   Nordlandssykehuset HF;   Sykehuset Innlandet HF;   Helse Forde;   Helse Fonna HF;   Helse Nord-Trøndelag HF;   Helse Møre og Romsdal HF;   Sykehuset Telemark Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials